Appian Named A Visionary in Gartner's 2018 Magic Quadrant for Enterprise High-Productivity Application Platform as a Service
RESTON, Va., May 11, 2018 (GLOBE NEWSWIRE) -- Appian (NASDAQ:APPN) today announced it has been named a Visionary by Gartner in its 2018 Magic Quadrant for Enterprise High-Productivity Application Platform as a Service. The report evaluates vendors in the enterprise high-productivity application platform as a service (hpaPaaS) market and their product offerings.
The report noted: "High-productivity application platform as a service continues to increase its footprint across enterprise IT as businesses juggle the demand for applications, digital business requirements and skill set challenges."
The report also defined hpaPaaS as that which, "provides rapid application development (RAD) features for development, deployment and execution - in the cloud."
"In today's landscape, enterprises are under more pressure than ever to transform operations and customer experiences through custom software," said Malcolm Ross, Vice President of Product Marketing at Appian. "Low-code platforms amplify the productivity of software developers to meet the growing business demand. With Appian, business and IT can work collaboratively to build new software solutions, enhance legacy applications already in place, and continuously transform digital business operations. We are pleased to be recognized by Gartner, which we feel further validates the value we bring to the market."
To view a complimentary copy of the report, click HERE .
Gartner, "Magic Quadrant for Enterprise High-Productivity Application Platform as a Service," Paul Vincent, Van L. Baker, et al., 26 April 2018.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
This press release includes forward-looking statements. All statements contained in this press release other than statements of historical facts, including, without limitation, Appian's deployment of innovative technologies, strong focus on vertical markets, large professional services group and global reach through partnerships with global system integrators are forward-looking statements. The words "anticipate," believe," "continue," "estimate," "expect," "intend," "may," "will" and similar expressions are intended to identify forward-looking statements. Appian has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that Appian believes may affect its financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs. Those forward-looking statements are subject to a number of risks and uncertainties, including, without limitation, risks related to Appian's ability to innovate and provide a platform that is useful to its customers, risks related to Appian's ability to further penetrate existing industry verticals and expand into other industry verticals, risks related to Appian's professional services group and the deployment services provided by such group to its customers, risks associated with international operations and the expansion of sales to customers outside of the United States, risks related to the success of Appian's strategic relationship with third parties, and the risks and uncertainties set forth in the "Risk Factors" section of Appian's Annual Report on Form 10-K for the year ended December 31, 2017 filed with the Securities and Exchange Commission, and subsequent reports that Appian has filed with the Securities and Exchange Commission. Moreover, Appian operates in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for Appian's management to predict all risks, nor can Appian assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements Appian may make. In light of these risks, uncertainties and assumptions, Appian cannot guarantee future results, levels of activity, performance, achievements or events and circumstances reflected in the forward-looking statements will occur. Appian is under no duty to update any of these forward-looking statements after the date of this press release to conform these statements to actual results or revised expectations, except as required by law.
Appian provides a leading low-code software development platform that enables organizations to rapidly develop powerful and unique applications. The applications created on Appian's platform help companies drive digital transformation and competitive differentiation. For more information, visit www.appian.com .
For Information Contact:
Director of Media Relations
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
Erytech Pharma S.A.16.7.2019 22:02:00 CEST | Press release
ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 21, 2019
WSO215.7.2019 15:02:38 CEST | Press release
WSO2 Introduces WSO2 API Microgateway 3.0 to Simplify Creating, Deploying and Securing APIs in Microservice Environments
Lubrizol15.7.2019 08:01:33 CEST | Press release
Lubrizol Acquires Bavaria Medizin Technologie GmbH
PBSC Urban Solutions13.7.2019 00:03:47 CEST | Press release
H.S.H. PRINCE ALBERT II LAUNCHES MONABIKE, MONACO’S NEW FULLY-ELECTRIC BIKE SHARE FROM PBSC URBAN SOLUTIONS
Lubrizol11.7.2019 19:02:04 CEST | Press release
Lubrizol Integrates Personal, Home and Health Care Divisions; Now Lubrizol Life Science
XBiotech Inc.11.7.2019 14:31:47 CEST | Press release
Dr. Seth Forman to Chair XBiotech’s Second Phase 2 Study of Bermekimab in Atopic Dermatitis
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum